Inpatient management of diabetes

Primary Care - Clinics in Office Practice

Volumn 30, Issue 3, 2003, Pages 557-567

  McDonough, Karen A ^a,b   DeWitt, Dawn E ^a,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALPHA GLUCOSIDASE INHIBITOR; CORTICOSTEROID; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; MIGLITOL; PIOGLITAZONE; PREDNISONE; REPAGLINIDE; ROSIGLITAZONE; THIAZOLIDINE DERIVATIVE;

BLOATING; CLINICAL PROTOCOL; CRITICAL ILLNESS; DEATH; DIABETES MELLITUS; DRUG USE; EDEMA; ELECTROLYTE DISTURBANCE; ERYTHRODERMA; FLATULENCE; FLUID BALANCE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HEART FAILURE; HUMAN; HYPERGLYCEMIA; INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; KETOACIDOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT; POSTOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; TREATMENT PLANNING;

EID: 0141652799     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0095-4543(03)00036-8     Document Type: Review

References (28)

1. McCowan KC, Malhotra A, Bistrian B. Endocrine and metabolic dysfunction syndromes in the critically ill: stress induced hyperglycemia. Crit Care Clin 2001;17:107-24.
2. Fath-Ordoubadi F, Beatt KJ. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction. Circulation 1997;96:1152-6.
3. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355:773-8.
4. Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke 2001;32:2426-32.
5. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002;87:978-82.
6. Alexiewicz J, Kumar D, Smogorzewski M, Klin M, Massry S. Polymorphonuclear leukocytes in non-insulin dependent diabetes mellitus: abnormalities in metabolism and function. Ann Intern Med 1995;123:919-24.
7. McMahon MM, Bistrian BR. Host defenses and susceptibility to infection in patients with diabetes mellitus. Infect Dis Clin North Am 1995;9:1-9.
8. Latham R, Lancaster A, Covington J, Pirolo J, Thomas C. The association of diabetes and glucose control with surgical site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 2001;22:607-12.
9. Zerr K, Furnary A, Grunkemeier G, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997;63:356-61.
10. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patient. N Engl J Med 2001;345:1359-67.
11. Malmberg K, Ryden L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol 1995;26:57-65.
12. McGlynn TJ, Simons RJ. Endocrine disorders. In: Gross RJ, Caputo GM, editors. Medical consultation: the internist on surgical, obstetric, and psychiatric services. 3rd edition. Baltimore: William and Wilkins; 1998. p. 329-34.
13. Rayner CK, Jones KL, Samson M, Horowitz M. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 2001;24:371-81.
14. Gillies PS, Figgitt DP, Lamb HM. Insulin glargine. Drugs 2000;59:253-60; discussion, 261-2.
15. Brown G, Dodek P. Intravenous insulin nomogram improves blood glucose control in the critically ill. Crit Care Med 2001;29:1714-9.
16. Simmons D, Morton K, Laughton SJ, Scott DJ. A comparison of two intravenous insulin regimens among surgical patients with insulin-dependent diabetes mellitus. Diabetes Educ 1994;20:422-7.
17. Hirsch IB, Paauw DS. Diabetes management in special situations. Endocrinol Metab Clin North Am 1997;26:631-45.
18. Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med 1997;157:545-52.
19. Lenhard MJ, Reeves GD. Continuous subcutaneous insulin infusion: a comprehensive review of insulin pump therapy. Arch Intern Med 2001;161:2293-300.
20. Park HR, Hansell DT, Davidson LE, Henderson G, Legge V, Gray G. Management of diabetic patients requiring nutritional support. Nutrition 1992;8:316-20.
21. Sajbel TA, Dutro MP, Radway PR. Use of separate insulin infusions with total parenteral nutrition. Journal of Parenteral and Enteral Nutrition 1987;11:97-9.
22. Calabrese AT, Coley KC, DaPos SV, Swanson D, Rao RH. Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy. Arch Intern Med 2002;162:434-7.
23. Hirsch IB, Kelly J, Cooper S. Pulmonary edema associated with troglitazone therapy. Arch Intern Med 1999;159.
24. Woltorton E. Rosiglitazone and pioglitazone and heart failure. CMAJ 2002;166:219-20.
25. Niemeyer NV, Janney LM. Thiazolidinedione induced edema. Pharmacotherapy 2002;22:924-9.
26. Delea T, Hagiwara M, Edelsberg J, Oster G. Exposure to glitazone antidiabetics and risk of heart failure among persons with type 2 diabetes: a retrospective population-based cohort analysis. J Am Coll Cardiol 2002;39:(S)184A.
27. Arner P, Gunnarsson R, Blomdahl S, Groth CG. Some characteristics of steroid diabetes: a study in renal transplant recipients receiving high-dose corticosteroids. Diabetes Care 1983;6:23-5.
28. Roman SH, Chassin MR. Windows of opportunity to improve diabetes care when patients with diabetes are hospitalized for other conditions. Diabetes Care 2001;24:1371-6.